Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29640472 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL28302 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL5179069 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL20082 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| SCHEMBL30609972 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| Bicarbonate SCHEMBL20401648 | 0.80 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL5057657 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL1534045 | 0.80 | ALDH1A1 (0.35) | ALDH1A1 | |
| Ethylene SCHEMBL4370792 | 0.78 | ALDH1A1 (0.42) | ALDH1A1 | |
| SCHEMBL27708634 | 0.78 | ALDH1A1 (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399274-A1 | METHOD OF HARVESTING BIOLOGICS | Solventum Intellectual Properties Company (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240131450-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2024-04-25 | — | — | US | disclosed |
| EP-4297884-A1 | CHARGED DEPTH FILTER FOR THERAPEUTIC BIOTECHNOLOGY MANUFACTURING PROCESS | 3M Innovative Properties Company (US) | 2024-01-03 | — | — | EP | disclosed |
| WO-2023037178-A1 | METHOD OF HARVESTING BIOLOGICS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-03-16 | — | — | WO | disclosed |
| WO-2022136968-A1 | METHOD OF SEPARATING A VIRUS FROM A COMPOSITION USING COPOLYMER-GRAFTED NONWOVEN SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-30 | — | — | WO | disclosed |
| US-9821276-B2 | Nonwoven article grafted with copolymer | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-11-21 | — | — | US | disclosed |
| US-9738757-B2 | Composition and polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9463146-B2 | Addition-fragmentation oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-10-11 | — | — | US | disclosed |
| US-9434829-B2 | Ligand grafted substrates | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-09-06 | — | — | US | disclosed |
| US-20160222168-A1 | Composition and Polymer | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-08-04 | — | — | US | disclosed |
| US-20150203645-A1 | LIGAND GRAFTED SUBSTRATES | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-07-23 | — | — | US | disclosed |
| US-20150099413-A1 | NONWOVEN ARTICLE GRAFTED WITH COPOLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2015-04-09 | — | — | US | disclosed |
| US-8980969-B2 | Addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-03-17 | — | — | US | disclosed |
| US-20140256870-A1 | COMPOSITION AND FILM COMPRISING SAME | MITSUI CHEMICALS, INC. (JP) | 2014-09-11 | — | — | US | disclosed |
| US-7772348-B2 | optical resin, transparent, plastic lenses, high refractive index, heat resistance, strength; polythioether-polyene polymers; resin obtained by polymerization of metal-thiol compound; polythiourethanes, polythioether reacted with triallyl isocyanurate | MITSUI CHEMICALS, INC. (JP) | 2010-08-10 | — | — | US | disclosed |
| US-20080027198-A1 | Metal-Containing Compound and Use Thereof | MITSUI CHEMICALS, INC. (JP) | 2008-01-31 | — | — | US | disclosed |
| US-7074858-B2 | Reactive oligomers | HEILMANN STEVEN M | 2006-07-11 | — | — | US | disclosed |
| US-7015286-B2 | Reactive oligomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-03-21 | — | — | US | disclosed |
| US-20040059044-A1 | Oligomeric dyes and use thereof | 3M INNOVATIVE PROPERTIES COMPANY | 2004-03-25 | — | — | US | disclosed |
| US-20030212210-A1 | Reactive oligomers | 3M INNOVATIVE PROPERTIES COMPANY | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203645-A1 | LIGAND GRAFTED SUBSTRATES | SIGLEC7, SELPLG, SIGLEC9 | ALDH1A1 2090/4885 |
| US-20080027198-A1 | Metal-Containing Compound and Use Thereof | HSPH1, HSPA4L, PTCD3 | ALDH1A1 2543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.